Why the study?
Is serum CTRP9 concentration associated with arterial stiffness in subjects with type 2 diabetes?
Population
278 subjects with type 2 diabetes (169 men, 109 women; mean age 58.3 years)
Design
Cross-sectional
Authors
Loading...
Serum CTRP9 may mark arterial stiffness in T2D; hypothesis-generating and requires prospective validation before any clinical role.
Is serum CTRP9 concentration associated with arterial stiffness in subjects with type 2 diabetes?
Elevated serum CTRP9 concentration is independently associated with increased arterial stiffness in patients with type 2 diabetes.
Jung et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: